Treatment of herpesvirus associated primary effusion lymphoma with intracavity cidofovir

Leukemia. 2005 Mar;19(3):473-6. doi: 10.1038/sj.leu.2403646.
No abstract available

Publication types

  • Case Reports
  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Aged, 80 and over
  • Antineoplastic Agents / administration & dosage*
  • Antineoplastic Agents / therapeutic use
  • Cell Line, Tumor
  • Cell Proliferation / drug effects
  • Cell Survival / drug effects
  • Cidofovir
  • Cytosine / administration & dosage*
  • Cytosine / analogs & derivatives*
  • Cytosine / therapeutic use
  • Herpesvirus 8, Human / drug effects*
  • Humans
  • Injections, Intralesional
  • Lymphoma, B-Cell / drug therapy*
  • Lymphoma, B-Cell / virology
  • Lymphoma, Non-Hodgkin / drug therapy*
  • Lymphoma, Non-Hodgkin / virology
  • Male
  • Organophosphonates / administration & dosage*
  • Organophosphonates / therapeutic use
  • Remission Induction
  • Time Factors

Substances

  • Antineoplastic Agents
  • Organophosphonates
  • Cytosine
  • Cidofovir